Page breadcrumb nav

VAERS Report 2156668

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (MODERNA))

Type : Coronavirus 2019 vaccine

Fabricant: MODERNA

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

abnormal clotting factor; this case was received via regulatory authority (reference number: gb-mhra-adr 26655917) on 27-feb-2022 and was forwarded to moderna on 27-feb-2022. this regulatory authority case was reported by an other health care professional and describes the occurrence of abnormal clotting factor (abnormal clotting factor) in a male patient of an unknown age who received mrna-1273 (moderna covid-19 vaccine) for an unknown indication. no medical history information was reported. on an unknown date, the patient received dose of mrna-1273 (moderna covid-19 vaccine) (unknown route) 1 dosage form. on 24-feb-2022, the patient experienced abnormal clotting factor (abnormal clotting factor) (seriousness criteria hospitalization, disability and life threatening). at the time of the report, abnormal clotting factor (abnormal clotting factor) had not resolved. the action taken with mrna-1273 (moderna covid-19 vaccine) (unknown) was unknown. for mrna-1273 (moderna covid-19 vaccine) (unknown), the reporter did not provide any causality assessments. no concomitant product use was provided by the reporter. the patient experienced clotting and seizures.this reaction did not occur as a result of a mistake made in the administration of the vaccine. no treatment medication was provided. company comment: this is a regulatory case concerning an unknown-years-old male patient with no reported clinical history who experienced the unexpected event of abnormal clotting factor occured unknown days after a dose of rna-1273. also, case narrative summary mentioned "seizures" (aesi) the benefit-risk relationship of mrna-1273 vaccine is not affected by this report. terms and onset were captured as provided. the case was assessed as serious by the regulatory authority�s report due to life-threatening, hospitalization and disability; sender's comments: company comment: this is a regulatory case concerning an unknown-years-old male patient with no reported clinical history who experienced the unexpected event of abnormal clotting factor occured unknown days after a dose of rna-1273. also, case narrative summary mentioned "seizures" (aesi) the benefit-risk relationship of mrna-1273 vaccine is not affected by this report. terms and onset were captured as provided. the case was assessed as serious by the regulatory authority�s report due to life-threatening, hospitalization and disability

Données de laboratoire
na
Liste des symptômes
abnormal clotting factor
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Oui
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Oui
Allergies:
na
Maladie actuelle
na